IL6 and susceptibility to pneumonia measurement: They are also known to inhibit the release of pro-inflammatory cytokines, interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β), reducing pneumonia severity and mortality [31,32].